Gynuity Panels at the FIGO World Congress 2015

Gynuity hosted four panels at the upcoming FIGO World Congress in Vancouver this October. Gynuity staff and international colleagues will present the results of new research and discuss strategies and implications for postabortion care, first and second trimester medical abortion, and the management of postpartum hemorrhage (PPH).

Innovations to improve the quality and reach of postabortion care
In collaboration with the Post Abortion Care Consortium
Moderated by Beverly Winikoff

• Task shifting PAC: Time to rethink how and where postabortion care is offered? – Rasha Dabash
• A district approach to providing PAC at multiple levels and sectors of care: Lessons learned from demonstration projects in Egypt – Nevine Hassanein
• Decentralizing comprehensive PAC, including treatment by mid-level providers: in Senegal – Ayisha Diop
• Postabortion contraception and counseling: How can we better meet women’s FP needs – Paul Blumenthal
• Youth-friendly PAC services: What does it mean and why does it matter? – Callie Simon

Innovations in first and second trimester medical abortion services
Moderated by Jennifer Blum

• Simplifying medical abortion follow-up: The role of at home semi-quantitative pregnancy tests – Beverly Winikoff
• Can we eliminate the mifepristone clinic visit in medical abortion services? – Elizabeth Raymond
• Bridging the gap between first and second trimester abortion: The safety, efficacy, and acceptability of outpatient medical abortion services between 10 and 12 weeks – Selma Hajri
• Second trimester induction abortion: What we know about route and interval in mifepristone+misoprostol procedures – Dina Abbas
• Mifepristone plus misoprostol vs. misoprostol-alone for missed abortion – Hillary Bracken

Misoprostol and other uterotonics in the management of PPH: New evidence to guide clinical practice
In collaboration with FIGO
Moderated by Olufemi Oladapo

• Does route of oxytocin prophylaxis administration matter? Recent studies comparing intramuscular vs intravenous administration and their implications – Holly Anger
• Too much of a good thing? Does frequency of uterotonics in early stages of labor affect PPH rates and efficacy of treatment? – Mrinalini Balki
• Clinical indicators of PPH: What is PPH and when should we intervene? – Rodolfo Pacagnella
• A comparison of primary prevention vs. secondary prevention as community based strategies for PPH management utilizing misoprostol – Suellen Miller
• What went wrong? An analysis of PPH deaths in community based studies and what they tell us about the gaps in quality of PPH care – Beverly Winikoff

Misoprostol for PPH management: Service delivery strategies to address PPH where options are few
In collaboration with FIGO
Moderated by Paul Blumenthal

• Misoprostol vs oxytocin in Uniject for the prevention of PPH: Research from Senegal – Bocar Daff
• Misoprostol as “first aid” for PPH at the community level – Emad Darwish
• The safety and efficacy of misoprostol for the treatment of PPH after its use for prophylaxis: research from Pakistan and Afghanistan – Dina Abbas
• Prevention or treatment of PPH with uterotonics: Time for broader thinking and new approaches? – Rasha Dabash
• From research to programs: Evaluation of misoprostol for PPH scale-up programs in Nepal – Swaraj Rajbhandari

Additional presentations and posters

Time to redefine postpartum hemorrhage? The relationship between postpartum blood loss and change in pre- to post-delivery hemoglobin – Holly Anger

Medical abortion outcomes and repeat pregnancy following quickstart of contraceptive implants and depot-medroxyprogesterone acetate– Elizabeth Raymond

Can semi-quantitative pregnancy tests assist women undergoing IVF to monitor hCG levels outside of a clinic setting?– Paul Blumenthal

Bleeding after childbirth: Can a bleeding history questionnaire help identify women at risk of excess blood loss postpartum?– Jill Durocher

How real is the threat of fatal clostridial infection? Vaginal and rectial Clostridium sordellii and Clostridium perfringens presence among women in the United States – Beverly Winikoff

What happens when medical abortion services give women the option of taking mifepristone at home? – Laura Frye

On the trail of misoprostol in the community: a secondary analysis of self-administered misoprostol for the prevention of postpartum hemorrhage in Uganda– Laura Frye
Poster presentation

What happens when we routinely give doxycycline to medical abortion patients?– Laura Frye
Poster presentation

Maternal self-reports of postpartum bleeding: Findings from a trial of self-administered misoprostol in rural Uganda – Jill Durocher
Poster presentation